Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3560238, 6 pages
Review Article

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy

1Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
2Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, USA

Correspondence should be addressed to Shougang Zhuang; gro.napsefil@gnauhzs

Received 30 November 2016; Accepted 20 February 2017; Published 23 April 2017

Academic Editor: Secundino Cigarran

Copyright © 2017 Na Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Fengbo Wu, Sijia Li, Nan Zhang, Wei Huang, Xiang Li, Manyi Wang, Ding Bai, and Bo Han, “Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy,” Biomedicine & Pharmacotherapy, vol. 104, pp. 307–314, 2018. View at Publisher · View at Google Scholar
  • Jinfang Bao, Yingfeng Shi, Min Tao, Na Liu, Shougang Zhuang, and Weijie Yuan, “Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy,” Clinical Science, vol. 132, no. 21, pp. 2299–2322, 2018. View at Publisher · View at Google Scholar